| Autor: |
Ludvigsen M; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark. majlud@rm.dk.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. majlud@rm.dk., Campbell AJ; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Enemark MB; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Hybel TE; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Karjalainen-Lindsberg ML; Department of Pathology, Helsinki University Hospital, Helsinki, Finland., Beiske K; Department of Pathology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Bjerre M; Medical/Steno Aarhus Research Laboratory, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Pedersen LM; Zealand University Hospital, Roskilde, Denmark., Holte H; Department of Oncology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Center for B-Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Norwegian Cancer Genomics Consortium, Oslo, Norway., Leppä S; Research Program Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland., Jørgensen JM; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Honoré B; Department of Biomedicine, Aarhus University, Aarhus, Denmark. bh@biomed.au.dk. |
Full text from SpringerLink